the double beta-lactam combination of moxalactam plus piperacillin was compared with the aminoglycoside-containing regimen of moxalactam plus amikacin in a prospective , randomized trial of empiric therapy for 302 febrile episodes in granulocytopenic cancer patients .
C0002556
aminoglycoside
C0002499
amikacin